Following this, a transcriptomic study on breast cancer cells with CRISPR/Cas9 deleted ZNF 319 identified ZNF319 as a tumor suppressor gene, that reduces the proliferation in breast cancer and therefore is involved in various potential signaling mechanisms and other biological functions (Wang L. et al., 2022). The gene discussed is ZNF319; the disease is breast cancer.